India  

Amid efficacy row, Covaxin gets thumbs-up from Lancet

IndiaTimes Friday, 22 January 2021
Amid a raging controversy over the efficacy of Covaxin, India’s first indigenous Covid-19 vaccine, reputed medical journal the Lancet Infectious Diseases on Friday said the vaccine produced tolerable safety outcomes and enhanced immune responses in its Phase 1 trials.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Lancet publishes Covaxin phase 2 trials data

prestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens..
IndiaTimes

Mexico experts recommend approving Indian vaccine

A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company..
IndiaTimes

Govt sees Covaxin efficacy as validation of its scientific process

The phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and..
IndiaTimes
Covid vaccine explained: Covishield? Covaxin? Do's and Don'ts | Oneindia News [Video]

Covid vaccine explained: Covishield? Covaxin? Do's and Don'ts | Oneindia News

The second phase of India's covid vaccine drive is receiving an enthusiastic response. However, if you are hesitant about the vaccine since you are on medication or recently recovered from some serious illness or even Covid-19 for that matter, you may have some questions that we address in this video. #Covaxin #Covishield #CovidVaccine

Credit: Oneindia    Duration: 03:13Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

'Majority' of ITV shows back in production as COVID knocks profits

ITV says a "majority" of the programmes it makes are now back in production after coronavirus disruption knocked 2020 profits by a fifth.
Sky News
COVID-19: India reports 15,388 new cases, 77 deaths in last 24 hrs [Video]

COVID-19: India reports 15,388 new cases, 77 deaths in last 24 hrs

India reported 15,388 new COVID-19 cases and 16, 596 discharges with 77 deaths in the last 24 hours, as per the Union Health Ministry. 2.26 crore people vaccinated against COVID-19 in the country so far. The total active cases in India stand at 1,87,462.

Credit: ANI    Duration: 01:48Published
100 saints get COVID jab at Swaminarayan temple in Gujarat [Video]

100 saints get COVID jab at Swaminarayan temple in Gujarat

As the vaccination drive against COVID-19 is in full swing, around 100 saints at the Swaminarayan temple in Ahmedabad also received their shots on March 08. Interestingly, the jabs were given to the saints at the Swaminarayan temple where all the arrangements were done for the vaccination. The 2nd phase of the vaccination drive had started on March 01 which covers people above the age of 60 and those over 45 with existing health conditions.

Credit: ANI    Duration: 01:45Published

Related videos from verified sources

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN..

Credit: ANI     Duration: 01:42Published
Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’ [Video]

Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’

Tamil Nadu health minister C Vijayabaskar voluntarily took the vaccine Covaxin at Rajiv Gandhi Government General Hospital in Chennai. Vijayabaskar, who is a doctor and a member of the IMA, had earlier..

Credit: HT Digital Content     Duration: 02:14Published
It's against informed consent: Manish Tewari on people won't be able to choose vaccine [Video]

It's against informed consent: Manish Tewari on people won't be able to choose vaccine

Indian National Congress spokesperson Manish Tewari raised questions on COVAXIN's efficacy. He said, "Many eminent doctors have raised questions with regard to the efficacy and safety of COVAXIN with..

Credit: ANI     Duration: 02:32Published

Related news from verified sources

'Start vaccination drive only after proper screening'

'Start vaccination drive only after proper screening'
AS India is all set to begin vaccinations against COVID-19, health experts have raised concerns about allergic reactions as a side effect. Allergic reactions to...
Mid-Day

Covid cases, fatality sharply decline in Odisha

Covid-19 positive cases are hovering between 100 and 200 during the last one week. Thirteen people have lost their lives due to Covid in the last two weeks. Only...
IndiaTimes Also reported by •Mid-Day

What you need to know about Oxford COVID-19 vaccine

With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon...
Mid-Day Also reported by •IndiaTimes